It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …

Heart failure (HF) is a major and growing public health problem in the United States.
Approximately 5 million patients in this country have HF, and over 550 000 patients are …

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American
College of Cardiology Foundation/American Heart Association Task Force on Practice …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted through October 2011 and includes selected …

Late-breaking clinical trials presented at the 2005, 2006, and 2007 annual scientific
meetings of the ACCF, AHA, and European Society of Cardiology, as well as selected other …

Background Beta‐blockers and inhibitors of the renin‐angiotensin‐aldosterone system
improve survival and reduce morbidity in people with heart failure with reduced left …

The American College of Cardiology (ACC)/American Heart Association (AHA) Task Force
on Practice Guidelines regularly reviews existing guidelines to determine when an update or …

Nitrosamine impurities have been detected in various pharmaceutical products in recent
days. Various sartans, ranitidine, nizatidine, and metformin have been recalled from the …

Background: The role of angiotensin-receptor blockers (ARBs) in treating patients with
chronic heart failure and high-risk acute myocardial infarction (MI) has been controversial …

Background: Cancer cases have escalated by approximately 12% since 1900 and the
incidence rate has increased faster for females than males. The discovery of cisplatin in …